TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Algoquant Fintech Limited
ALGOQUANTSmall CapNSEBSE
Investment Services · Investment Services
₹64.56up 0.07up 0.11 percentas of 31 Aug 2026
Book value ₹4.78
Key metrics
- Market Cap
- 1,814.20 ₹ cr
- P/E
- 54.25 x
- P/B
- 13.50 x
- ROE
- 24.84%
- ROCE
- -105.70%
- Debt to Equity
- 0.25 x
- Net Margin
- —
- Dividend Yield
- —
- Revenue Growth (YoY)
- —
Observations
Mechanical observations generated from stored data, not analysis or opinion. Each one names the threshold that produced it — the ROCE check below uses 20%, a fixed default rather than a value tailored to this company.
- ROCE above 20% in 2 of the last 3 financial years (2023-2024, 2024-2025, 2025-2026).
- Revenue declined year-on-year in 1 of the last 3 years.
- Net margin declined year-on-year in 2 of the last 3 years.
- Promoter holding 73.7% (pledge data not available).
- Debt-to-equity 0.25 — below the Investment Services median of 0.57.
ALGOQUANT
₹64.56up 0.11 percent
EOD Synced: 31 Aug 2026 18:30 ISTOverview & Live Price Chart
Executive Investment Verdict & Quality Synthesis
Autonomous V2Multi-dimensional quantitative synthesis across capital efficiency, forensic accounting, intrinsic valuation, and ownership governance.
Factual Quantitative Consensus
1. Capital Efficiency & MoatCapital Intensive
-105.70%ROCE
ROE: 24.84%·P/B: 13.50x
2. Forensic Health & SolvencyPiotroski 6/9 · Adequate Health
6/9Piotroski Score
Altman: 1.2 (Grey Zone)
3. Valuation & DCF Spread+18.4% Margin of Safety
₹76DCF Fair Value
CMP: ₹64.6
4. Ownership & GovernanceClean Promoter Holding
73.68%Promoter Stake
Pledged: 0.0%·Inst: —
Institutional Factor Scores
QVGM Factor Grade Matrix
Institutional Multi-Factor Profile (QVGM)
Composite 0–100 percentile ranks normalized across all 500 universe constituents
Rank #15 of 27 in Investment ServicesQVGM 45/100
Quality (Q)48
ROE, ROCE, Margins & Cash Conversion
Value (V)25
P/E, P/B, EV/EBITDA vs Sector Benchmarks
Growth (G)50
3Y Sales & EPS Compounded Growth
Momentum (M)58
Relative Strength & Trend Position
TheScreener Radar™ 5-Pillar Quantitative Scorecard
Holistic quantitative radar evaluating fundamental quality, valuation multiples, balance sheet health, growth, and price momentum
Sector Rank:Rank #15 of 27 in Investment Services
Valuation
Weak25/100
P/E Ratio:54.25x
P/B Ratio:13.50x
Dividend Yield:0.00%
P/E, P/B, EV/EBITDA & Dividend Yield relative to 5Y medians and sector
Growth
Moderate50/100
3Y Sales CAGR:—
3Y PAT CAGR:—
Quarterly YoY:+12.4%
3-Year Compounded Sales & Net Profit Growth trajectory
Profitability
Moderate48/100
ROE:24.8%
ROCE:-105.7%
OPM %:—
Return on Equity (ROE), ROCE & Operating Margin efficiency
Solvency & Health
Moderate67/100
Piotroski F-Score:6/9
Altman Z-Score:1.15
Debt / Equity:0.00
Balance Sheet strength, Altman Z-Score & Piotroski F-Score checklist
Momentum
Moderate58/100
1Y Return:—
RSI (14):54.2
From 52W High:—
1-Year Relative Strength vs NIFTY 500, RSI-14 & 52W High distance
Quantitative Drivers & Growth Analysis
52-week corridor, deep valuation multiples, compounded CAGR trajectory, and institutional flow shifts
52-Week Low₹50.03
From 52W High-15.57%
52-Week High₹76.47
Valuation MultiplesCash Flow & Yield
PEG Ratio—
Earnings Yield1.84%
Price / FCF32.05
FCF Yield3.12%
Payout Ratio—
Net-Net Ratio5.84
Solvency & SafetyPiotroski & Altman
Piotroski F-Score6/9
Altman Z-Score1.15
Graham Number₹11.32
1Y Flow & Margin ShiftsTrailing 12M
FII Stake:▼ 0.41%
DII Stake:—
OPM Margin:—
Net Margin:—
Compounded Annual Growth Rate (CAGR Matrix)
Historical Fundamental Trajectory| Metric | QoQ Shift | YoY Shift | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Revenue Growth | — | — | — | — | — |
| Net Profit Growth | ▼ 1.90% | ▲ +271.17% | 2.52% | — | 55.03% |
| EPS Growth | ▼ 1.67% | ▲ +268.75% | 2.59% | — | 58.22% |
Intrinsic Valuation Models & DCF Sensitivity
Institutional DCF & Intrinsic Valuation Studio — ALGOQUANT
2-Stage Discounted Cash Flow, Reverse DCF Implied Growth, and Benjamin Graham & Peter Lynch valuation benchmarks.
DCF Intrinsic Fair Value
₹84.5
Verdict:Undervalued (+30.9%)
Benjamin Graham Number
₹11.3
-82.5% vs CMPPeter Lynch Fair Value
₹59.5
-7.8% vs CMPReverse DCF Implied Growth
24.7% CAGR
Modest Expectations (High Margin of Safety)Valuation Spectrum PositioningCMP: ₹64.6
₹0 (Distress)CMP: ₹65DCF: ₹84Graham: ₹11
Scenario Calibration & Sensitivity Levers
Tune Discount Rate (WACC), 5-Year Growth, and Terminal Value to model bear, base, and bull cases.
Discount Rate (WACC)11.5%
Cost of Capital Hurdle
5-Year FCF Growth CAGR30.0%
Assumed stage-1 cash flow expansionTerminal Growth Rate4.5%
Long-term perpetual GDP growth rate5-Year Projected Cash Flow Schedule (₹ Cr)
| Projection Period | Growth Rate | Projected FCF | Discount Factor | Present Value |
|---|---|---|---|---|
| Year 1 | 30% | ₹74 | 0.8969 | ₹66 |
| Year 2 | 30% | ₹96 | 0.8044 | ₹77 |
| Year 3 | 30% | ₹124 | 0.7214 | ₹90 |
| Year 4 | 30% | ₹162 | 0.6470 | ₹105 |
| Year 5 | 30% | ₹210 | 0.5803 | ₹122 |
2D Sensitivity Matrix (WACC vs Terminal Growth Rate)
Click any cell to apply WACC & terminal growth scenario. Values in ₹ / share.| WACC \ g(Terminal) | 3.0% | 4.0% | 4.5% | 5.0% | 6.0% |
|---|---|---|---|---|---|
| 10.0% | ₹89 +38% | ₹101 +56% | ₹109 +68% | ₹118 +83% | ₹143 +122% |
| 11.0% | ₹77 +19% | ₹86 +33% | ₹91 +41% | ₹98 +51% | ₹114 +77% |
| 11.5% | ₹72 +12% | ₹80 +24% | ₹84 +31% | ₹90 +39% | ₹103 +60% |
| 12.0% | ₹68 +5% | ₹75 +16% | ₹79 +22% | ₹83 +29% | ₹94 +46% |
| 13.0% | ₹61 -6% | ₹66 +2% | ₹69 +7% | ₹72 +12% | ₹80 +25% |
Discounted cash flow (DCF) and valuation models are quantitative projections based on user-supplied assumptions — not a forecast, not a guarantee of future performance, and not SEBI-registered investment advice. Actual financial performance and stock price movements may differ materially.
New to intrinsic valuation models? Learn how Discounted Cash Flow and Terminal Growth rates work.Read DCF Academy Guide →
Valuation history
P/E54.25current
ReportedComputed, approximate
P/B13.50current
ReportedComputed, approximate
The dashed line is computed from historical close price divided by the most recently reported annual EPS or book value — not IndianAPI's own figure, which only ever gives a single current reading with no history behind it. Real results are typically disclosed several weeks after the fiscal year ends, so a computed point right around a year transition can lag what the market actually knew that day. The solid line is the real reported figure.
EV/EBITDA is not shown — there is no verified source for it in our data feed, and estimating it would misrepresent an estimate as a reported figure.
| Date | P/E | P/B |
|---|---|---|
| 31 Aug 2026 | 54.25 | 13.50 |
Analyst Consensus, Price Targets & Forecasts
Analyst Ratings
No analyst consensus data available for this company.
Risk Profile & Volatility
Statistical return volatility classification · 31 Aug 2026
Balanced risk
Low RiskModerate RiskHigh Risk
Annualised Standard Deviation:36.19%
Analyst Price Targets
12-month forward price consensus · 20 Aug 2026
Upside: +3,234.37%
Mean Target₹2,152.67vs CMP ₹64.56
High Target₹2,300.44+3463.3% max upside
Low Target₹1,692.952522.3% downside
Median Target₹2,136.2545 estimates
Low: ₹1,692.95Mean: ₹2,152.67High: ₹2,300.44
Mean Target Current Price (₹64.56)
Price targets are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Forward Financial Forecasts & Consensus Estimates
Institutional broker consensus estimates and forward earnings trajectory
FY2027E11 Analysts
Mean Estimate
₹19.93
Low:—
High:—
FY2027E11 Analysts
Mean Estimate
₹20.98
Low:—
High:—
FY2027E11 Analysts
Mean Estimate
₹22.03
Low:—
High:—
FY2027E11 Analysts
Mean Estimate
₹23.08
Low:—
High:—
FY2028E11 Analysts
Mean Estimate
₹22.88
Low:—
High:—
FY2028E11 Analysts
Mean Estimate
₹24.08
Low:—
High:—
FY2028E11 Analysts
Mean Estimate
₹25.28
Low:—
High:—
FY2028E11 Analysts
Mean Estimate
₹26.49
Low:—
High:—
| Period / Fiscal Year | Consensus Mean | Bull Case (High) | Bear Case (Low) | Brokers |
|---|---|---|---|---|
| FY2027 Forecast | ₹19.93 | — | — | 11 |
| FY2027 Forecast | ₹20.98 | — | — | 11 |
| FY2027 Forecast | ₹22.03 | — | — | 11 |
| FY2027 Forecast | ₹23.08 | — | — | 11 |
| FY2028 Forecast | ₹22.88 | — | — | 11 |
| FY2028 Forecast | ₹24.08 | — | — | 11 |
| FY2028 Forecast | ₹25.28 | — | — | 11 |
| FY2028 Forecast | ₹26.49 | — | — | 11 |
Third-party broker forecasts compiled from institutional research houses, not IndiScreener's proprietary estimates. Provided strictly for analytical benchmarking and does not constitute investment advice.
Forensic Accounting Audit & Solvency Risk
Accounting Health & Governance Quality Radar
Algorithmic accounting analysis across balance sheet solvency, cash conversion efficiency, and ownership stability.
Clean Governance & Solvency
Financial Strengths & Catalysts
4 Factors- •Company has delivered a high Return on Equity (ROE) of 24.8%.
- •Company maintains conservative leverage with D/E of 0.25x.
- •Strong cash generation: Operating Cash Flow is 179.6% of reported Net Profit.
- •High promoter holding of 73.7% with zero encumbrance / pledge.
Risk Factors & Watchouts
0 WatchoutsClean profile: No major debt, leverage, or working capital red flags detected.
Forensic Accounting & Health Audit
Piotroski F-Score, Altman Z-Score Distress Model & Beneish Earnings Manipulation Checks
Piotroski F-Score6 / 9
● Moderate (Neutral)
Altman Z-Score1.15
● Grey Zone
Moderate risk; company exhibits average leverage and liquidity.
Beneish M-Score-3.75
● Low Risk (Clean Accounting)
Cash flows closely match reported earnings with conservative accruals.
Learn how Piotroski F-Score (9 criteria) and Altman Z-Score detect earnings manipulation and bankruptcy risk.Read Forensic Guide →
10-Year Financial Statements & DuPont ROE
Financial Statements
consolidated · amounts in ₹ Crores
Accounting Flow:
Wall Street Cash Flow & Free Cash Flow (FCF) Cascade
FY26 (2025-2026)3-Stage institutional flow from reported earnings to owner Free Cash Flow and capital allocation
FCF Conversion Rate (FCF / PAT)
169.5%Elite Cash Quality (>100%)
Measures how much reported accounting profit turns into real liquid cash.
Free Cash Flow Margin
—of Gross Revenue
Liquid cash retained per ₹100 of top-line revenue generated.
CapEx Reinvestment Rate
5.7%of Operating Cash
Portion of operating cash reinvested in future capacity and maintenance.
Reported Net Profit (PAT)₹33 CrInflow
33
+ D&A Non-Cash Charge₹4 CrAdd-back
4
Working Capital Adjustment₹22 Cr+ Cash
22
= Operating Cash Flow (CFO)₹60 CrOperating Cash
60
- Capital Expenditures (CapEx)-₹3 CrReinvestment
3
= Free Cash Flow (FCF)₹57 CrFree Cash Flow
57
- Dividends & Debt Repayment-₹7 CrCapital Return
7
= Net Change in Cash₹50 CrNet Balance
50
Multi-Year Historical FCF vs Reported PAT Trajectory:
Free Cash Flow (FCF) Reported Net Profit (PAT)
| Metric | 2020-202131 Mar 2021 | 2021-202231 Mar 2022 | 2022-202331 Mar 2023 | 2023-202431 Mar 2024 | 2024-202531 Mar 2025 | 2025-202631 Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | ₹3.24 | ₹16.39 | ₹12.84 | ₹156.28 | ₹234.55 | — |
| Operating profit | ₹0.78 | ₹3.09 | ₹-5.77 | ₹40.84 | ₹44.29 | ₹-154.93 |
| OPM | 24.07% | 18.85% | -44.94% | 26.13% | 18.88% | — |
| Net profit | ₹3.73 | ₹3.43 | ₹-3.42 | ₹24.82 | ₹32.58 | ₹33.40 |
| EPS | 0.12 | 2.69 | -0.14 | 0.88 | 1.16 | 1.19 |
| Net margin | 115.12% | 20.93% | -26.64% | 15.88% | 13.89% | — |
| ROE | 18.55% | 10.23% | -9.97% | 35.91% | 32.00% | 24.84% |
| ROCE | 3.88% | 8.85% | -16.79% | 52.87% | 39.94% | -105.70% |
| Debt / equity | 0.07 | 0.00 | 0.89 | 0.94 | 0.33 | 0.25 |
Compounded growth (CAGR)
| Metric | 1Y | 3Y | 5Y |
|---|---|---|---|
| Revenue | — | — | — |
| Net profit | 2.52% | — | 55.03% |
| EPS | 2.59% | — | 58.22% |
Each column only appears when 6 real reported years actually support it — never extrapolated from fewer.
Balance sheet
| Metric | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|
| Total assets | ₹25.32 | ₹43.26 | ₹71.84 | ₹303.83 | ₹216.33 | ₹275.19 |
| Total liabilities | ₹5.21 | ₹9.72 | ₹37.55 | ₹234.71 | ₹114.51 | ₹140.72 |
| Total equity | ₹20.11 | ₹33.54 | ₹34.29 | ₹69.11 | ₹101.82 | ₹134.47 |
| Total debt | ₹1.46 | ₹0.00 | ₹30.47 | ₹64.92 | ₹34.07 | ₹34.27 |
| Cash | ₹0.28 | ₹0.30 | ₹0.31 | ₹192.35 | ₹115.20 | ₹129.99 |
| Current assets | ₹25.13 | ₹10.59 | ₹60.50 | ₹283.41 | ₹187.51 | ₹246.63 |
| Current liabilities | ₹5.21 | ₹8.35 | ₹37.47 | ₹226.58 | ₹105.45 | ₹128.62 |
| Inventory | — | — | — | — | — | — |
| Receivables | ₹0.83 | ₹0.00 | — | ₹1.28 | ₹1.72 | ₹1.58 |
| Payables | ₹0.20 | ₹1.40 | ₹0.88 | ₹7.51 | ₹5.54 | ₹8.52 |
| Net PP&E | ₹0.00 | ₹1.14 | ₹1.73 | ₹12.68 | ₹13.82 | ₹12.96 |
| Retained earnings | — | — | — | — | — | — |
Cash flow
| Metric | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|
| Operating cash flow | ₹-17.89 | ₹20.18 | ₹-37.20 | ₹-0.83 | ₹60.13 | ₹60.00 |
| Capital expenditure | — | ₹-1.18 | ₹-0.82 | ₹-4.39 | ₹-3.59 | ₹-3.39 |
| Free cash flow | — | ₹19.00 | ₹-38.02 | ₹-5.22 | ₹56.54 | ₹56.61 |
| OCF / net profit | -4.80 | 5.88 | 10.88 | -0.03 | 1.85 | 1.80 |
| FCF / Capex intensity | — | 7.20 | 6.39 | 2.81 | 1.53 | — |
Income statement detail
| Metric | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|
| Gross profit | — | — | — | ₹155.74 | ₹233.74 | — |
| Cost of revenue | — | — | — | ₹0.54 | ₹0.80 | — |
| EBITDA | ₹0.78 | ₹3.13 | ₹-5.55 | ₹43.99 | ₹48.87 | ₹-150.67 |
| Income before tax | ₹4.42 | ₹3.16 | ₹-6.49 | ₹30.96 | ₹37.80 | ₹41.48 |
| Interest expense | ₹0.12 | ₹0.64 | ₹1.48 | ₹9.09 | ₹5.96 | — |
| Tax expense | ₹0.67 | ₹-0.07 | ₹-3.56 | ₹6.15 | ₹5.22 | ₹8.08 |
| D&A | ₹0.00 | ₹0.04 | ₹0.22 | ₹3.15 | ₹4.58 | ₹4.26 |
| EBITDA margin | 24.07% | 19.10% | -43.22% | 28.15% | 20.84% | — |
Financial ratios
| Metric | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|
| Current ratio | 4.82 | 1.27 | 1.61 | 1.25 | 1.78 | 1.92 |
| Quick ratio | — | — | — | — | — | — |
| Interest coverage | 6.50 | 4.83 | -3.90 | 4.49 | 7.43 | — |
| Inventory days | — | — | — | — | — | — |
| Receivable days | 93.50 | 0.00 | — | 2.99 | 2.68 | — |
| Payable days | — | — | — | — | 2,527.63 | — |
| Cash conversion cycle | — | — | — | — | — | — |
| Working capital days | — | — | — | — | — | — |
| Fixed asset turnover | — | 14.38 | 7.42 | 12.32 | 16.97 | — |
| ROA | 14.73% | 7.93% | -4.76% | 8.17% | 15.06% | 12.14% |
| ROIC | 3.11% | 9.50% | -4.04% | -56.12% | 184.50% | -321.94% |
| Gross margin | — | — | — | 99.65% | 99.65% | — |
DuPont ROE Decomposition
DuPont analysis requires complete net margin, asset turnover, and equity multiplier metrics for the latest fiscal period. At least one of those hasn't been ingested yet for this company.
Explore the 3-Stage DuPont Formula: Net Margin × Asset Turnover × Leverage Multiplier.Read DuPont Guide →
Corporate Actions, Dividends & Capital Changes
Chronological Corporate Actions Registry
Historical stock splits, bonus shares, rights issues, and corporate schemes
| Year | Execution Date | Action Type | Ratio / Term |
|---|---|---|---|
| 2025 | 18 Aug 2025 | split | 1:2 |
| 18 Aug 2025 | bonus | 8:1 | |
| 08 Jan 2025 | bonus | 1:2 | |
| 2021 | 24 Dec 2021 | split | 2:10 |
Industry Peer Group & Valuation Spread
Compare valuation multiples and market cap relative to sector competitors
Investment ServicesCompare Peers in Studio
Market Cap1,814.20 ₹ cr
Beats 85% of 13 industry peers · median 783.19 ₹ cr
P/E54.25 x
Beats 91% of 11 industry peers · median 26.68 x
P/B13.50 x
Beats 100% of 11 industry peers · median 1.09 x
ROE24.84%
Beats 100% of 12 industry peers · median 8.65%
ROCE-105.70%
Beats 0% of 7 industry peers · median 5.47%
Debt to Equity0.25 x
Beats 42% of 12 industry peers · median 0.57 x
| Company | Market Cap ▼ | P/E | P/B |
|---|---|---|---|
| ₹11,198.26 | 28.27 | 2.53 | |
| ₹3,200.33 | 21.78 | 2.37 | |
5Paisa Capital Limited5PAISA | ₹1,674.30 | 26.08 | 1.77 |
AK Capital Services LimitedAKCAPIT | ₹1,155.00 | 10.22 | 1.08 |
| ₹1,064.45 | 11.14 | 0.86 |
Peers are chosen strictly by industry classification. A classification doesn't always describe what a company actually competes in, but gives an objective starting point across the universe.
Regulatory Filings & Market Intelligence
Corporate Document & Filings Vault
No statutory exchange announcements or PDF filings have been recorded for ALGOQUANT yet.
News
No news has been ingested for this company yet.
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.